An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism
暂无分享,去创建一个
S. Rowland-Jones | J. Trowsdale | A. McMichael | J. Sutton | A. Hill | F. Gotch | W. Rosenberg | S. Powis | I. Mockridge | N. Murray
[1] S. Rowland-Jones,et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides , 1993, European journal of immunology.
[2] M. Aidoo,et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.
[3] N. Huskisson,et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.
[4] T Spies,et al. Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Rammensee,et al. Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man , 1992, European journal of immunology.
[6] S Beck,et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Cresswell,et al. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.
[8] Sarah L. Rowland-Jones,et al. Genetic modulation of antigen presentation by HLA-B27 molecules , 1992, The Journal of experimental medicine.
[9] A. Townsend,et al. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.
[10] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[11] O. Rötzschke,et al. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. , 1991, Immunology today.
[12] Peter Walden,et al. Exact prediction of a natural T cell epitope , 1991, European journal of immunology.
[13] E. Pamer,et al. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.
[14] S. Beck,et al. Second proteasome-related gene in the human MHC class II region , 1991, Nature.
[15] S. Beck,et al. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.
[16] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[17] Robert DeMars,et al. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.
[18] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[19] J. Monaco,et al. MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.
[20] J. Monaco,et al. Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.
[21] S. Beck,et al. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.
[22] R. Demars,et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.
[23] Hans-Georg Rammensee,et al. Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.
[24] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[25] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[26] P. Cresswell,et al. Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.
[27] S. Powis,et al. A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule , 1989, The Journal of experimental medicine.
[28] C Summers,et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.
[29] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[30] J. Bastin,et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.
[31] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[32] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[33] A. McMichael,et al. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 , 1987, Nature.
[34] B. Moss,et al. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes , 1987, The Journal of experimental medicine.
[35] J. Davey,et al. Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.
[36] J. D. de Vries,et al. Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. , 1982, Journal of immunology.
[37] S. Fields,et al. The structure of the gene encoding the nucleoprotein of human influenza virus A/PR/8/34. , 1981, Virology.
[38] J. Monaco,et al. A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.
[39] H. Ljunggren,et al. A mutant cell in which association of class I heavy and light chains is induced by viral peptides. , 1989, Cold Spring Harbor symposia on quantitative biology.
[40] M. Epstein,et al. Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. III. Establishment of HLA‐restricted cytotoxic T cell lines using interleukin 2 , 1982, European journal of immunology.